BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2015 1:27:00 PM | Browse: 1387 | Download: 2363
 |
Received |
|
2015-05-19 09:11 |
|
Peer-Review Started |
|
2015-05-20 08:01 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2015-08-27 11:03 |
|
Revised |
|
2015-11-11 01:17 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-12-01 10:37 |
|
Second Decision by Editor-in-Chief |
|
2015-12-02 20:07 |
|
Final Decision by Editorial Office Director |
|
2015-12-14 15:54 |
|
Articles in Press |
|
2015-12-14 15:54 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-12-21 10:10 |
|
Publish the Manuscript Online |
|
2015-12-31 13:27 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Topic Highlights |
| Article Title |
Prophylactic managements of hepatitis B viral infection in liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Takashi Onoe, Hiroyuki Tahara, Yuka Tanaka and Hideki Ohdan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Japanese Ministry of Health, Labour and Welfare |
for the Research of Hepatitis and BSE |
|
| Corresponding Author |
Dr. Takashi Onoe, MD, PhD, Head, Division of Applied Immunobiology, Institute for Clinical Research, National Hospital Organization, Kure Medical Center/Chugoku Cancer Center, 3-1 Aoyama-cho, Kure, Hiroshima 737-0023, Japan. tonoemd@gmail.com
|
| Key Words |
Liver transplantation; Hepatitis B infection; prophylaxis; nucleos(t)ide analogue; anti-hepatitis B immunoglobulin |
| Core Tip |
Combination therapy consisting of high-dose hepatitis B immunoglobulin (HBIG) and lamivudine has been the standard prophylaxis for hepatitis B virus recurrence after liver transplantation. Currently, after development of more potent high genetic barrier nucleos(t)ide analogues (hgbNAs), such as entecavir and tenofovir disoproxil fumarate, combination therapy using low-dose HBIG and hgbNA is considered as the most efficacious and cost-effective prophylaxis. In addition, monotherapy with hgbNAs and withdrawal of HBIG following combination therapy of HBIG and hgbNAs could be promising approaches, especially for low-risk patients and those receiving grafts from hepatitis B core antibody-positive donors. This review discusses those approaches including other challenging therapeutic options.
|
| Publish Date |
2015-12-31 13:27 |
| Citation |
Onoe T, Tahara H, Tanaka Y, Ohdan H. Prophylactic managements of hepatitis B viral infection in liver transplantation. World J Gastroenterol 2016; 22(1): 165-175 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i1/165.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i1.165 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
